Novella
Novella (operating as IQVIA Biotech) is a full-service clinical research organization providing specialized clinical development services to biotech innovators across oncology, cell & gene therapy, CNS, cardiovascular, dermatology, and internal medicine therapeutic areas.
- Company typePrivate
- Founded2019
- HeadquartersMorrisville, United States
- Headcount501–1,000
- GTM typeB2B
- OfferingServices
What Novella does
Novella, originally founded in 1998 in Morrisville, NC, is a full-service clinical research organization (CRO) that has been integrated into IQVIA and now operates under the IQVIA Biotech brand as a dedicated biotech-focused CRO. The company delivers end-to-end clinical development services to biotech innovators, with productized offerings across six therapeutic verticals: Oncology, Cell & Gene Therapy, Central Nervous System (CNS), Cardiovascular/Renal/Metabolic (CVRM), Dermatology, and Internal Medicine. Its core platform is specialized dedicated teams that combine therapeutic-area expertise with regulatory and operational know-how to move breakthrough therapies from innovation through patient impact. The technology and data backbone leverages the broader IQVIA ecosystem, including the IQVIA Institute for Human Data Science, providing access to industry-level datasets and insights that inform protocol design and clinical strategy.
The business operates on a professional services, quote-based engagement model typical of enterprise CROs, with no publicly disclosed pricing. Go-to-market is anchored on enterprise field sales targeting biotech companies directly, complemented by a multi-channel marketing motion spanning the iqviabiotech.com content hub, webinars on emerging modalities (ADCs, cell & gene therapy for autoimmune disease, neurodegenerative therapies, master protocols), and presence at major industry events such as ASCO and Clinical Trials in Oncology East Coast. The company claims global reach, serving biotech sponsors across geographies under the IQVIA umbrella.
Customer segmentation is vertical and persona-based, targeting "biotech innovators" — emerging and mid-sized biopharma companies driving the drug development pipeline. The company competes in the specialized biotech CRO segment against other mid- and large-tier CROs, with differentiation rooted in therapeutic-area specialization rather than scale alone. Operating leadership is anchored by President & CEO W. Richard Staub III. Headcount sits in the 501-1000 range, consistent with a mid-sized specialized CRO operating as a focused sub-brand within a much larger parent organization.
Novella firmographics
Firmographics- Name
- Novella
- Legal name
- IQVIA Biotech
- Website
- https://novellaclinical.com
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- Novella (operating as IQVIA Biotech) is a full-service clinical research organization providing specialized clinical development services to biotech innovators across oncology, cell & gene therapy, CNS, cardiovascular, dermatology, and internal medicine therapeutic areas.
- Ownership category
- akta.pro rank
Novella industry classification
Industry- Product category
- Contract Research Organization (CRO) / Clinical Research Services
- NAICS
- Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171)
- SIC
- Services-Health Services (8000)
- akta.pro primary industry
- Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL)
Keywords
Where Novella is headquartered
LocationHeadquarters
- HQ city
- Morrisville
- HQ country
- United States
- HQ region
- North America
Markets served
Novella business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Clinical Development Services: Full-service CRO services for biotech companies including clinical trial management, regulatory support, and therapeutic expertise across multiple specialized areas
Go-to-market motion1 record
Distribution channels2 records
Marketing channels4 records
Novella product offering
Product offeringCore offering
Novella Clinical is a full-service contract research organization (CRO) providing clinical trial management, regulatory support, and therapeutic-area expertise to biotech companies. The company is focused primarily on emerging oncology customers and, as part of IQVIA Biotech, delivers specialized clinical development solutions across oncology, cell & gene therapy, CNS, cardiovascular/renal/metabolic, dermatology, and internal medicine. Novella provides dedicated specialized teams, strategic problem-solving, and global reach to move biotech innovations from development to patient impact.
Product overview
IQVIA Biotech is a biotech-specialized full-service CRO providing clinical development solutions. The offering consists of a core clinical development platform complemented by specialized therapeutic areas including Oncology, Cell & Gene Therapy, CNS, Cardiovascular/Renal/Metabolic, Dermatology, and Internal Medicine. The platform delivers dedicated teams, strategic problem-solving, and regulatory expertise to help biotech innovators advance their treatments from innovation to patient impact.
Differentiator
Problem solved
Functional benefit
Products and services
- Clinical Development Services Full-service clinical development with specialized, dedicated teams that help biotech companies design, manage, and execute clinical trials, including trial management, regulatory support, and strategic problem-solving across therapeutic areas.
- Oncology Clinical Trials Specialized clinical trial solutions for oncology drug developers, applying innovative approaches to accelerate breakthrough discoveries through clinical development to patients.
- Cell & Gene Therapy Clinical Trials Pioneering clinical trial services for cell and gene therapy developers, designed to cut through complexity and advance novel advanced therapies through clinical development.
- Central Nervous System (CNS) Clinical Trials Hyper-specialized clinical trial services for central nervous system therapies, providing expertise and navigation support to simplify the complexity of CNS trials.
- Cardiovascular, Renal & Metabolic (CVRM) Clinical Trials Specialized clinical trial services for cardiovascular, renal, and metabolic (CVRM) therapies, applying unique expertise to bring CVRM treatments to patients faster.
- Dermatology Clinical Trials Tailored clinical trial services for dermatology innovations, applying therapeutic expertise to advance novel dermatology treatments through clinical development.
- Internal Medicine Clinical Trials Highly specialized clinical trial services for internal medicine therapies, applying customized strategies across multiple internal medicine subspecialties to ensure trial success.
Companies that use Novella
Customer profileSegments1 record
Ideal customer profiles1 record
Novella technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Novella partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- IQVIAcoreIQVIA Biotech operates as a specialized division within the larger IQVIA organization. This subsidiary leverages the broader company's resources, data capabilities, and global infrastructure to provide specialized services to biotech companies. The relationship involves shared technology, data science capabilities, and institutional knowledge across the IQVIA ecosystem.
Scale indicators2 records
Recent moves6 records
Expansion highlights5 records
Novella competitors and assessment
Company assessmentMarket position
Strengths4 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Novella social profiles
Digital presenceNovella financial estimates
Financial estimateRevenue estimate
Valuation estimate
Novella leadership team
Management profileNumber of profiles
Profiles1 record
Novella funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Novella M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Novella
What does Novella do?
Novella Clinical is a full-service contract research organization (CRO) providing clinical trial management, regulatory support, and therapeutic-area expertise to biotech companies. The company is focused primarily on emerging oncology customers and, as part of IQVIA Biotech, delivers specialized clinical development solutions across oncology, cell & gene therapy, CNS, cardiovascular/renal/metabolic, dermatology, and internal medicine. Novella provides dedicated specialized teams, strategic problem-solving, and global reach to move biotech innovations from development to patient impact.
Is Novella a public or private company?
Novella is a private company. It is classified as corporate owned and is currently operating.
When was Novella founded?
Novella was founded in 2019. It employs 501 to 1,000 people.
Where is Novella based?
Novella is headquartered in Morrisville, United States, in the North America region.
How does Novella make money?
One revenue line is on record: clinical Development Services.
Does Novella have an API?
No public API is recorded for Novella.
What industry is Novella in?
Novella's product category is Contract Research Organization (CRO) / Clinical Research Services. Its primary akta.pro industry code is HLAGAAAL, Specialty Therapeutic-Area CROs (e.g., oncology/rare disease). Its NAICS code is 5417 and its SIC code is 8000.